-- 
Barclays, GSK, RBS, Camco: U.K., Irish Equity Preview

-- B y   B l a n c h e   G a t t
-- 
2011-09-22T06:41:35Z

-- http://www.bloomberg.com/news/2011-09-21/barclays-camco-international-rbs-u-k-irish-equity-preview.html
The following is a list of
companies that may have unusual share-price changes in U.K. and
Irish markets. Stock symbols are in parentheses and prices are
from the last market close.  The FTSE 100 Index declined 75.30 points, or 1.4 percent,
to 5,288.41. The FTSE All-Share Index fell 1.3 percent to
2,742.17, while Ireland’s ISEQ Index dropped 1.9 percent to
2,444.52.  GlaxoSmithKline Plc (GSK)  : Goldman Sachs Group Inc.
raised its view on the U.K. drugmaker to “neutral” from
“sell.” The shares fell 0.3 percent to 1,330 pence.  Barclays Plc (BARC)  :  Lehman Brothers  Holdings Inc. said
it will drop its appeal of a judge’s ruling in an $11 billion
lawsuit against Barclays Plc over the 2008 sale of some of
Lehman’s operations. Lehman Brothers also won’t appeal a judge’s
ruling in a dispute with Barclays over $500 million in bonuses,
a spokeswoman said. The shares fell 0.7 percent to 153.25 pence.  Camco International Ltd. (CAO)  : The London-based
developer of emission credits won two clean-energy contracts in
Africa worth $1.8 million in revenue over the next three years.
The shares jumped 5.4 percent to 14.63 pence.  Royal Bank of Scotland Group Plc (RBS)  : Britain’s
biggest government-owned bank received bids for its aircraft-
leasing operation from commercial lender CIT Group Inc. and
Jackson Square Aviation LLC, three people familiar with the
sales process said. The shares gained 1.3 percent to 23.38
pence.  To contact the reporter on this story:
Blanche Gatt in London at 
 bgatt@bloomberg.net   To contact the editor responsible for this story:
Colin Keatinge at 
 ckeatinge@bloomberg.net  